Nave KA - Search Results

1

Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases.

Krauter D, Stausberg D, Hartmann TJ, Volkmann S, Kungl T, Rasche DA, Saher G, Fledrich R, Stassart RM, Nave KA, Goebbels S, Ewers D, Sereda MW. Krauter D, et al. Among authors: nave ka. EMBO Mol Med. 2024 Mar;16(3):616-640. doi: 10.1038/s44321-023-00019-5. Epub 2024 Feb 21. EMBO Mol Med. 2024. PMID: 38383802 Free PMC article.

2

Mouse models of myelin diseases.

Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. Werner H, et al. Among authors: nave ka. Brain Pathol. 1998 Oct;8(4):771-93. doi: 10.1111/j.1750-3639.1998.tb00200.x. Brain Pathol. 1998. PMID: 9804383 Free PMC article. Review.

3

The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.

Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. Niemann S, et al. Among authors: nave ka. Ann N Y Acad Sci. 1999 Sep 14;883:254-61. Ann N Y Acad Sci. 1999. PMID: 10586250 Review.

4

Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22.

Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA. Niemann S, et al. Among authors: nave ka. J Neurosci. 2000 Jun 1;20(11):4120-8. doi: 10.1523/JNEUROSCI.20-11-04120.2000. J Neurosci. 2000. PMID: 10818147 Free PMC article.

5

The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells.

Schneider S, Bosse F, D'Urso D, Muller H, Sereda MW, Nave K, Niehaus A, Kempf T, Schnolzer M, Trotter J. Schneider S, et al. J Neurosci. 2001 Feb 1;21(3):920-33. doi: 10.1523/JNEUROSCI.21-03-00920.2001. J Neurosci. 2001. PMID: 11157078 Free PMC article.

6

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.

Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. Lappe-Siefke C, et al. Among authors: nave ka. Nat Genet. 2003 Mar;33(3):366-74. doi: 10.1038/ng1095. Epub 2003 Feb 18. Nat Genet. 2003. PMID: 12590258

7

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Sereda MW, et al. Among authors: nave ka. Nat Med. 2003 Dec;9(12):1533-7. doi: 10.1038/nm957. Epub 2003 Nov 9. Nat Med. 2003. PMID: 14608378

8

Axonal neuregulin-1 regulates myelin sheath thickness.

Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. Michailov GV, et al. Among authors: nave ka. Science. 2004 Apr 30;304(5671):700-3. doi: 10.1126/science.1095862. Epub 2004 Mar 25. Science. 2004. PMID: 15044753

9

High cholesterol level is essential for myelin membrane growth.

Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. Saher G, et al. Among authors: nave ka. Nat Neurosci. 2005 Apr;8(4):468-75. doi: 10.1038/nn1426. Epub 2005 Mar 27. Nat Neurosci. 2005. PMID: 15793579

10

Cre/loxP-mediated inactivation of the bHLH transcription factor gene NeuroD/BETA2.

Goebbels S, Bode U, Pieper A, Funfschilling U, Schwab MH, Nave KA. Goebbels S, et al. Among authors: nave ka. Genesis. 2005 Aug;42(4):247-52. doi: 10.1002/gene.20138. Genesis. 2005. PMID: 16028233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

368 results

Search Page